ClinicalTrials.gg
Drug

Omaveloxolone clinical trials

Also written RTA 408, BIIB141 and SKYCLARYS.

studies test it
16
open now
0
in phase 3
1
first study started
2013

How each study uses omaveloxolone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
28 Feb 2023 · SKYCLARYS · NDA 216718 (FDA, Drugs@FDA)
European Union
9 Feb 2024 · Skyclarys · EMEA/H/C/006084 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Omaveloxolone
11

Brand

SKYCLARYS
3

Development codes

RTA 408
8
BIIB141
5

Studies by the year they started

16 studies that test it; most in 2025 (4)

Studies that test omaveloxolone, by start year
YearStudies
20132
20142
20181
20193
20232
20242
20254

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 0

Biogen (16)

Often tested with

Tested in the same studies.

Omeprazole (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test omaveloxolone, phase 3 first.

Studies

Open first, then newest update. How each study uses omaveloxolone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call omaveloxolone · ClinicalTrials.gg INT000033

  • MeSH (NLM) C000589490omaveloxoloneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) G69Z98951QOMAVELOXOLONEConfirmed FDA, NLM, Wikidata
  • Wikidata Q21098900omaveloxoloneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C113443OmaveloxoloneOne source FDA
  • DrugBank DB12513One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.